No Data
OnKure Therapeutics (OKUR) Receives a Rating Update From a Top Analyst
OnKure Therapeutics Downgraded to Hold From Buy at JonesResearch
OnKure Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 EPS Results.
Express News | OnKure Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 EPS Results
Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), OnKure Therapeutics (OKUR) and Cogent Biosciences (COGT)
Analysts Offer Insights on Healthcare Companies: Revvity (RVTY), Option Care Health (OPCH) and OnKure Therapeutics (OKUR)